These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 947541)

  • 1. Synthesis of 8-O-(alpha-L-arabinofuranosyl)-beta-peltatin-A.
    Schwabe K; Graffi A; Tschiersch B
    Carbohydr Res; 1976 Jun; 48(2):277-81. PubMed ID: 947541
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective tumor DNA synthesis inhibition: in vivo prodrug activation by an exogenous enzyme.
    Tschiersch B; Schwabe K; Sydow G; Graffi A
    Cancer Treat Rep; 1977 Nov; 61(8):1489-93. PubMed ID: 21745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiments to increase the selectivity of tumor chemotherapy by means of in vivo activation of transport forms of cancerostatics by exogenous enzymes.
    Graffi A; Arnold W; Sydow G; Schwabe K; Arndt D; Pehl E
    Neoplasma; 1978; 25(4):377-84. PubMed ID: 29245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytological effect of chemicals on ascites sarcomas. III. Damage induced by podophyllotoxin, alpha-peltatin, beta-peltatin and quercetin.
    TANAKA T; KANO K; TONOMURA A; OKADA TA; UMETANI M
    Gan; 1955 Mar; 46(1):15-26. PubMed ID: 14380575
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and collagenase inhibition of new glycosides of aranciamycinone: the aglycon of the naturally occurring antibiotic aranciamycin.
    Bols M; Binderup L; Hansen J; Rasmussen P
    Carbohydr Res; 1992 Nov; 235():141-9. PubMed ID: 1335359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective variations in toxicity of new transport forms of carcinostatics produced by exogenous enzymes. 2. Beta-peltatin A-alpha-L-arabinofuranoside and alpha-L-arabinofuranosidase].
    Tschiersch B; Schwabe K; Sydow G; Graffi A
    Pharmazie; 1978 Jun; 33(6):358-61. PubMed ID: 28536
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of podophyllotoxin, alpha-peltatin and beta-peltatin on the cytochrome oxidase activity of sarcoma 37.
    WARAVDEKAR VS; DOMINGUE A; LEITER J
    J Natl Cancer Inst; 1952 Oct; 13(2):393-407. PubMed ID: 12991048
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estrogenic and antineoplastic activity of a series of transformed analogs of estrone and estradiol].
    Sorokina IB; Barkova TI; Zakharychev AA; Chigir' RN; Ananchenko SN
    Izv Akad Nauk SSSR Biol; 1973; 5():664-70. PubMed ID: 4761310
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of polyvinypyrrolidone on the antineoplastic and toxic properties of some antiblastomatous preparations].
    Kochetkova VA
    Farmakol Toksikol; 1967; 30(6):740-5. PubMed ID: 4175252
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study of the anti-tumor effect of complicated PDI(2-chlorethyl) aminophenylacetic acid esters with estrogens].
    Larionov LF; Sof'ina ZP; Lagova ND; Shkodinskaia EN; Iaguzhinskaia VP; Vasina OS
    Vopr Onkol; 1968; 14(11):61-4. PubMed ID: 5729488
    [No Abstract]   [Full Text] [Related]  

  • 11. [The preparation and properties of glycosides with cytotoxic aglycones and disaccharides in the sugar moiety].
    Arndt D; Hülsmann W; Tschiersch B
    Pharmazie; 1978 May; 33(5):248-50. PubMed ID: 674329
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic efficiency and effect on tumour growth of heterospecific antilymphocytic and antitumour sera.
    Woodruff M; Smith LH
    Nature; 1970 Jan; 225(5230):377-9. PubMed ID: 5410518
    [No Abstract]   [Full Text] [Related]  

  • 13. Four isomeric ethyl 1-thioglycosides from 2-amino-2-deoxy-D-arabinose.
    Wolfrom ML; Inouye S
    Carbohydr Res; 1975 May; 41():117-33. PubMed ID: 1137834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N 6 -Substituted adenosines: synthesis, biological activity, and some structure-activity relationships.
    Fleysher MH
    J Med Chem; 1972 Feb; 15(2):187-91. PubMed ID: 4550333
    [No Abstract]   [Full Text] [Related]  

  • 15. Concepts for controlling drug-resistant tumor cells.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
    Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
    [No Abstract]   [Full Text] [Related]  

  • 16. Damage induced in sarcoma 37 with podophyllin, podophyllotoxin alpha-peltatin, beta-peltatin, and quercetin.
    LEITER J; DOWNING V; HARTWELL JL; SHEAR MJ
    J Natl Cancer Inst; 1950 Jun; 10(6):1273-93. PubMed ID: 14774701
    [No Abstract]   [Full Text] [Related]  

  • 17. [Change in the weight of certain lymphoid organs as a criterion of the toxic action of antitumor preparations].
    Maliugina LL; Pol'kina RI
    Vopr Onkol; 1974; 20(3):62-9. PubMed ID: 4439803
    [No Abstract]   [Full Text] [Related]  

  • 18. Further studies on the metabolic effects of 9-beta-D-arabinofuranosyl-9-H-purine-6-thiol.
    Kimball AP; LePage GA; Allinson PS
    Cancer Res; 1967 Jan; 27(1):106-16. PubMed ID: 6066998
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme changes induced in normal and malignant tissues with chemical agents. IV. Effect of alpha-peltatin on glucose utilization by sarcoma 37 and on the adenosinetriphosphatase, hexokinase, aldolase, and pyridine nucleotide levels of sarcoma 37.
    WARAVDEKAR VS; PARADIS AD; LEITER J
    J Natl Cancer Inst; 1955 Aug; 16(1):31-9. PubMed ID: 13243111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
    Miuller NR; Remizov AL; Belogorodskiĭ VV; Filov VA
    Farmakol Toksikol; 1975; 38(5):590-1. PubMed ID: 1191387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.